Forest plot of the meta-analysis for the non-semaglutide comparison using crude hazard ratios with exclusion of overlapping cohorts
It's not clear if Ozempic, also made by Novo Nordisk, will be available for the same price
And second is that they have a lot of control on their supply chain
The effect is dose-dependent: higher doses are more likely to trigger symptoms, which is why slow dose escalation is the standard medical approach
Faseb J 29:LB280 Ahamad N, Kar A, Mehta S, Dewani M, Ravichandran V, Bhardwaj P, Sharma S, Banerjee R (2021) Immunomodulatory nanosystems for treating inflammatory diseases
This produced significant differences in insulin secretion (a difference of 21% in fasting insulin) but no difference in fat loss between the two diets